Searched for
THERAPEUTIC PLASMA EXCHANGE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have been in a corrective phase for some time. When corrections are sparked by global events, they may be short time-wise, but ...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 30%2025 has not been an easy year for the bulls. When we say bulls, we include retail investors. That’s because all retail investors are, by n...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have a big element of probability. The way things have panned out in the past few weeks, it is very likely that the bulls will ...
- MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
- Biohacker millionaire Bryan Johnson injects horse tranquilizer for new experiment. Here’s what happened to his brainTech entrepreneur and biohacker Bryan Johnson conducted a self-experiment by injecting ketamine and tracking his brain activity for 15 days...
- The Hitchhiker’s Guide to Immortality: Tech entrepreneur Bryan Johnson on 'don’t die' philosophy and mortalityTech entrepreneur Bryan Johnson visited Mumbai, advocating for his "Don't Die" philosophy. He highlighted India's air quality issues, empha...
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
- These large-caps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 27%As the correction continues unabated, a divergence is emerging in what is happening to the Nifty and Sensex and what is happening in the en...
- Can you become young again? Tech mogul Bryan Johnson claims "super plasma" helped his father decrease his age by 25 yearsTech millionaire Bryan Johnson took to X, formerly Twitter, to brag about his his “liquid gold” plasma in his latest social media post. He ...
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...
- States are making best use of technology to combat covid-19: Lav AgarwalThe facilities at these cities are mapping each Covid-19 positive case using GIS, tracking health care workers using GPS and drawing up con...
- ICMR releases plasma trials protocol, seeks registrationsConvalescent plasma is an experimental procedure for COVID-19 patients. As per the guidelines, hospitals and institutions planning to provi...
- Budget 2011: Finance Bill 2011A BILL to give effect to the financial proposals of the Central Government for the financial year 2011-2012. Be it enacted by Parliament in...
- Spain's Grifols plans to buy Talecris for $3.4 bnSpanish health care company Grifols plans to expand in the U.S. with the $3.4 billion purchase of plasma company Talecris Biotherapeutics.
Load More
